...
机译:评估万古霉素初始给药方案的适当性以及新的给药载体的发展
Department of Clinical Pharmacology and TherapeuticsSeoul National University College of Medicine;
Department of Clinical Pharmacology and TherapeuticsSeoul National University College of Medicine;
Department of Clinical Pharmacology and TherapeuticsSeoul National University College of Medicine;
Department of Laboratory MedicineSeoul National University College of Medicine and HospitalSeoul;
Department of Internal MedicineSeoul National University College of Medicine and HospitalSeoul Korea;
Department of Clinical Pharmacology and TherapeuticsSeoul National University College of Medicine;
Department of Clinical Pharmacology and TherapeuticsSeoul National University College of Medicine;
机译:评估万古霉素初始给药方案的适当性以及新的给药载体的发展
机译:根据修订的《日本2016年抗菌药物治疗药物监测指南》,使用常规计算机软件和诺法图得出万古霉素的初始剂量设定后测得的谷值比较
机译:由于克阳性微生物在少于90℃的克阳性微生物治疗后期发病败血症的定期剂量方案与万古霉素的标准给药方案为期(Neovanc):用于随机对照试验的研究方案
机译:低剂量专用全3D乳房CT系统的开发和初步演示
机译:新型基于遗传的华法林剂量诺模图的开发和验证。
机译:万古霉素的最佳剂量方案与标准剂量方案相比可用于治疗新生儿和90天以下婴儿革兰氏阳性微生物引起的晚期脓毒症(NeoVanc):一项随机对照试验的研究方案
机译:评估万古霉素初始给药方案的适当性和新的给药载体的发展